North Carolina Translational and Clinical Science Institute (NC TraCS) KL2
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2
批准号:
10362720
负责人:
Morris Weinberger
金额:
$182.21万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-03-30 至 2023-06-30
关键词:
AdoptedAdvisory CommitteesBackClinical SciencesCollaborationsCompetenceDevelopmentDisciplineEducational CurriculumElementsEnvironmentFacultyFeedbackFundingGoalsGrantHomeIndustryInstitutesInterdisciplinary StudyLeadershipLearningMentorsMethodologyNational Center for Advancing Translational SciencesNatureNorth CarolinaPathway interactionsPeer GroupPeer ReviewPhilosophyPositioning AttributePrincipal InvestigatorProgram DevelopmentResearchResearch PersonnelSchoolsScienceShapesTeacher Professional DevelopmentThinkingTimeTrainingTraining ActivityTraining ProgramsTranscendTranslational ResearchUniversitiesWorkWorkforce Developmentcareer developmentexperienceinnovationmembernext generationnovelpeerprogramsresiliencerole modelskillssuccesstranslational research programtranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
I. Institutional Career Development Core Abstract
The UNC/TraCS KL2 is the flagship program through which we shape the development of junior translational
scientists to become Principal Investigators and research leaders. Since our inception, we have funded 63
Scholars: 15 are currently supported on the KL2, and 48 have completed the Program. Of these 48, 46 are
funded academic investigators; one is a clinician; and one holds a research position in industry. Our success to
date is exemplified by the fact that 73% of our “graduated” Scholars have received significant (over $100,000
for a single grant) independent PI funding within 54 months of their starting the KL2. Our Scholars represent 6
Schools and 17 departments, a diversity that not only distinguishes this KL2 from other training programs on
campus, but also encourages and facilitates translational collaborations among Scholars who might not
otherwise cross paths. This highly successful program is grounded in a philosophy of team science across
disciplines, schools, and centers/institutes; an outstanding corps of expert faculty who are committed to work
closely with the mentors and Scholars as part of a coordinated team approach to faculty development; program
leadership that keeps abreast of the evolving scientific and programmatic priorities of the CTSA Program; and
a collegial culture in which our former Scholars willingly continue to be engaged and give time and expertise
back to the program as role models, mentors, and collaborators.
Going forward, the KL2 Program is adapting to the changing nature of our applicant pool and the evolving
translational workforce pipeline by replacing the mandatory two-year curriculum with personalized training
pathways developed by Scholars in collaboration with KL2 program faculty and their mentors. In addition, we
have established the KL2 Alumni Advisory Team, in which KL2 graduates provide feedback about training
components and advice on new content or redesign of how current content is delivered. Other changes include
increasing collaborative activities with the CTSA Consortium, integrating new initiatives such as the NCATS
Trial Innovation Network and TraCS Workforce Development Program into training activities, expanding
activities in mentoring, and introducing a set of competencies in scientific and research leadership. Goal 1:
Train KL2 Scholars to apply their disciplinary expertise to translational science and equip them with the
strategic thinking and management skills needed to create and sustain transformative interdisciplinary
translational research programs in a rapidly changing environment. Goal 2: Provide KL2 Scholars with the
skills to mentor members of their own research teams as well as the next generation of investigators.
TraCS serves as a true “home” for early-stage researchers who wish to engage in shared learning, peer review
and, most importantly, the development of a peer group that encourages innovation, resilience, and retention in
science. Our KL2 Program provides Scholars with experiences that enable them to transcend methodologic
boundaries, adopt concepts from other disciplines, and produce truly transformative translational science.
期刊论文(114)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jpeds.2021.11.025
发表时间:
2022-03
期刊:
The Journal of pediatrics
影响因子:
--
作者:
[Sanderson KR, Warady B, Carey W, Tolia V, Boynton MH, Benjamin DK, Jackson W, Laughon M, Clark RH, Greenberg RG]
通讯作者:
Greenberg RG
DOI:
10.1016/j.bbr.2022.113999
发表时间:
2022-09-05
期刊:
BEHAVIOURAL BRAIN RESEARCH
影响因子:
2.7
作者:
[Pessin, Sally, Walsh, Erin C., Hoks, Roxanne M., Birn, Rasmus M., Abercrombie, Heather C., Philippi, Carissa L.]
通讯作者:
Philippi, Carissa L.
DOI:
10.1097/cce.0000000000000647
发表时间:
2022-03
期刊:
Critical care explorations
影响因子:
--
作者:
[Wendlandt B, Ceppe A, Gaynes BN, Cox CE, Hanson LC, Nelson JE, Carson SS]
通讯作者:
Carson SS
DOI:
10.1016/j.semcdb.2021.08.011
发表时间:
2022-03
期刊:
Seminars in cell & developmental biology
影响因子:
7.3
作者:
[Little-Letsinger SE, Rubin J, Diekman B, Rubin CT, McGrath C, Pagnotti GM, Klett EL, Styner M]
通讯作者:
Styner M
DOI:
10.1016/j.jpeds.2021.03.013
发表时间:
2021-07
期刊:
The Journal of pediatrics
影响因子:
--
作者:
[deJong NA, Wofford M, Song PH, Kappelman MD]
通讯作者:
Kappelman MD
共 70 条
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2
-
批准号:10116520
-
项目类别:
-
资助金额:$190.03万
-
财政年份:2018
-
负责人:Morris Weinberger
-
依托单位:
CTSA KL2 Supplement Rebecca Grzadzinski
-
批准号:10117614
-
项目类别:
-
资助金额:$10.95万
-
财政年份:2018
-
负责人:Morris Weinberger
-
依托单位:
UNC Mentored Career Development Program in Comparative Effectiveness Research
-
批准号:8016132
-
项目类别:
-
资助金额:$199.24万
-
财政年份:2010
-
负责人:Morris Weinberger
-
依托单位:
COMMUNITY BASED PHARMACEUTICAL CARE--A CONTROLLED TRIAL
-
批准号:2237446
-
项目类别:
-
资助金额:$59.07万
-
财政年份:1996
-
负责人:Morris Weinberger
-
依托单位:
COMMUNITY-BASED PHARMACEUTICAL CARE: A CONTROLLED TRIAL
-
批准号:2714192
-
项目类别:
-
资助金额:$65.04万
-
财政年份:1996
-
负责人:Morris Weinberger
-
依托单位:
COMMUNITY-BASED PHARMACEUTICAL CARE: A CONTROLLED TRIAL
-
批准号:2430868
-
项目类别:
-
资助金额:$53.17万
-
财政年份:1996
-
负责人:Morris Weinberger
-
依托单位:
COMMUNITY-BASED PHARMACEUTICAL CARE: A CONTROLLED TRIAL
-
批准号:6017350
-
项目类别:
-
资助金额:$23.25万
-
财政年份:1996
-
负责人:Morris Weinberger
-
依托单位:
COST-BENEFIT OF EASING BURDEN OF ALZHEIMERS CAREGIVERS
-
批准号:3056619
-
项目类别:
-
资助金额:$1.73万
-
财政年份:1989
-
负责人:Morris Weinberger
-
依托单位:
COST-BENEFIT OF EASING BURDEN OF ALZHEIMERS CAREGIVERS
-
批准号:3056618
-
项目类别:
-
资助金额:$3.3万
-
财政年份:1989
-
负责人:Morris Weinberger
-
依托单位:
海外基金